Tagraxofusp Proves Effective for BPDCN, A Rare Blood Cancer Cancer Currents: An NCI Cancer Research Blog, 15 May 2019 New findings from a clinical trial of the drug tagraxofusp confirm its efficacy against the rare blood cancer blastic…